中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2010年
9期
1175-1176
,共2页
张波%郭雁冰%安贺军%司英奎
張波%郭雁冰%安賀軍%司英奎
장파%곽안빙%안하군%사영규
高血压%化红降纤汤%血液流变学
高血壓%化紅降纖湯%血液流變學
고혈압%화홍강섬탕%혈액류변학
Hypertension%Huahongjiangxian decoction%Hemorheology
目的 观察化红降纤汤对高血压患者血液流变学和血浆纤维蛋白原(FIB)的影响.方法 高血压患者100例,随机分为治疗组50例,对照组50例,分别用化红降纤汤和阿司匹林治疗8周,检测治疗前后两组血液流变学和FIB等指标.结果 治疗组治疗后全血黏度低切、红细胞变形指数、红细胞聚集指数差异有统计学意义(P<0.01),并优于对照组(P<0.05),对照组血小板聚集率的改善优于治疗组,但无统计学意义.结论 化红降纤汤可有效地降低高血压患者血黏度,改善机体红细胞和纤溶功能,有益于动脉硬化的防治及减少血栓性事件的发生.
目的 觀察化紅降纖湯對高血壓患者血液流變學和血漿纖維蛋白原(FIB)的影響.方法 高血壓患者100例,隨機分為治療組50例,對照組50例,分彆用化紅降纖湯和阿司匹林治療8週,檢測治療前後兩組血液流變學和FIB等指標.結果 治療組治療後全血黏度低切、紅細胞變形指數、紅細胞聚集指數差異有統計學意義(P<0.01),併優于對照組(P<0.05),對照組血小闆聚集率的改善優于治療組,但無統計學意義.結論 化紅降纖湯可有效地降低高血壓患者血黏度,改善機體紅細胞和纖溶功能,有益于動脈硬化的防治及減少血栓性事件的髮生.
목적 관찰화홍강섬탕대고혈압환자혈액류변학화혈장섬유단백원(FIB)적영향.방법 고혈압환자100례,수궤분위치료조50례,대조조50례,분별용화홍강섬탕화아사필림치료8주,검측치료전후량조혈액류변학화FIB등지표.결과 치료조치료후전혈점도저절、홍세포변형지수、홍세포취집지수차이유통계학의의(P<0.01),병우우대조조(P<0.05),대조조혈소판취집솔적개선우우치료조,단무통계학의의.결론 화홍강섬탕가유효지강저고혈압환자혈점도,개선궤체홍세포화섬용공능,유익우동맥경화적방치급감소혈전성사건적발생.
Objective To observe the effect of Huahongjiangxiantang on hemorheology and plasma fibrinogen (FIB).Methods 100 patients with hypertension were randomly divided into two groups:the treatment group ( n=50) which were treated with Huahongjiangxian-tang,and the control group( n=50)were treated with Aspirin.Hemorheology and plasma fibrin were detected before and after treatment for 8 weeks.Results After 8 weeks treatment,there were significant depressions in whole blood viscosity(low shear rate),RBC deformability index and RBC aggregation index( P<0.01 ),and better than the control group( P <0.05 ).There were significant changes in whole blood viscosity ( high shear rate),plasma viscosity,RBC rigidity index and plasma fibrin ( P < 0.05 ).A number of indicators declined significantly in control group ( P < 0.05 );The rate of platelet aggregation to improve the situation in the control group was better than that of the treatment group,but there was no statistical significance.Conclusion Huahongjiangxiantang can effectively reduce blood viscosity in patients with hypertension and improve the body's red blood cell function and fibrinolysis,benefit to the prevention and treatment of atherosclerosis and reduce the occurrence of thrombotic events.